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Abstract
Background: Pneumonia ranks as one of the main infectious sources of mortality among kids under 5 years of age,
killing 2500 a day; late research has additionally demonstrated that mortality is higher in the elderly. A few biomarkers,
which up to this point have been distinguished for its determination lack specificity, as these biomarkers fail to build
up a differentiation between pneumonia and other related diseases, for example, pulmonary tuberculosis and Human
Immunodeficiency Infection (HIV). There is an inclusive global consensus of an improved comprehension of the
utilization of new biomarkers, which are delivered in light of pneumonia infection for precision identification to defeat
these previously mentioned constraints. Antimicrobial peptides (AMPs) have been demonstrated to be promising
remedial specialists against numerous illnesses. This research work sought to identify AMPs as biomarkers for three
bacterial pneumonia pathogens such as Streptococcus pneumoniae, Klebsiella pneumoniae, Acinetobacter baumannii
using in silico technology. Hidden Markov Models (HMMER) was used to identify putative anti-bacterial pneumonia
AMPs against the identified receptor proteins of Streptococcus pneumoniae, Klebsiella pneumoniae, and Acinetobacter
baumannii. The physicochemical parameters of these putative AMPs were computed and their 3-D structures were
predicted using I-TASSER. These AMPs were subsequently subjected to docking interaction analysis against the
identified bacterial pneumonia pathogen proteins using PATCHDOCK.
Results: The in silico results showed 18 antibacterial AMPs which were ranked based on their E values with significant
physicochemical parameters in conformity with known experimentally validated AMPs. The AMPs also bound the
pneumonia receptors of their respective pathogens sensitively at the extracellular regions.
Conclusions: The propensity of these AMPs to bind pneumonia pathogens proteins justifies that they would be
potential applicant biomarkers for the recognizable detection of these bacterial pathogens in a point-of-care POC
pneumonia diagnostics. The high sensitivity, accuracy, and specificity of the AMPs likewise justify the utilization of
HMMER in the design and discovery of AMPs for disease diagnostics and therapeutics.
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ligands
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Background
Pneumonia disease is an infection of the lung parenchyma
and it is one of the major causes of critical illness through-
out the world [1]. Approximately, 150 million cases occur
every year among children under 5 years of age and the eld-
erly, resulting in approximately 20 million hospitalizations.
Treatment of the disease is hampered by a lack of sensitive
diagnosis [2] as biomarkers which hitherto have been iden-
tified for its diagnosis, lack specificity because they are im-
plicated in other diseases such as pulmonary tuberculosis
and Human Immunodeficiency Virus (HIV). The growing
problems of diagnosis of this disease and the difficulty of re-
sistance to conventional antibiotics, there is growing atten-
tion in the laboratory and pharmacological application of
antimicrobial peptides to detect and treat infections.
Five diagnostic biomarkers have been linked to the diag-
nosis of pneumonia, namely: C-reactive protein (CRP), Pro-
calcitonin (PCT), a Soluble triggering receptor expressed
on myeloid cells-1 (STREM-1), CD163, and High Mobility
Group Box-1(HMGB-1). CRP and PCT have been proven
useful in diagnosis as they are produced in considerably
high concentration but there is ambiguity in their specificity
towards pneumonia because they can be produced in re-
sponse to other inflammatory stimuli in the neuron, athero-
sclerotic plaques, myocytes, and lymphocytes [3]; whilst,
the mechanism regulating their syntheses at these sites is
not clearly understood [4]. There are other biomarkers that
are currently being studied for their probable link with
pneumonia diagnosis; these include copeptin, cortisol,
endotoxin, pro-adrenomedullin, amongst others, yet their
roles in pneumonia are not understood [3].
Apart from this, the methods of detection of the bio-
markers implicated in pneumonia disease have been con-
stantly advanced, ranging from poor sensitivity of blood
cultures [5], the inability of X-ray to identify the causative
pathogen [6], overwhelming lack of sensitivity and specifi-
city of the polymerase chain reaction [7], inability to iden-
tify only a few bacterial pneumonia pathogens in matrix-
assisted laser desorption or ionization-time of flight [8], to
expensive and lack of sensitivity of immunofiltration and
turbidimetric immunoassay [9]. The implication of the use
of these methods for pneumonia biomarkers identification
is the generation of false-negative and false-positive results
in patients [6]. It is therefore important to explore other
more reliable methods with improved sensitivity and
accuracy towards pneumonia.
Furthermore, antimicrobial peptides (AMPs) are part of
the innate immune systems that shield multicellular organ-
isms from a diverse spectrum of micro-organisms [10].
They have sequence composition that is family-specific
which can be used to discover and design novel ones [11].
They generally have therapeutic efficacy to microbial targets
when compared to conventional antibiotics with other
compensatory advantages ranging from expansive broad-
spectrum activities, low toxicity, and low resistance by mi-
crobes. These significant advantages give them huge
popularity and attention as novel antimicrobial agents.
Previous research has also reported the use of AMPs as
diagnostic agents against p24 of HIV [12] which were sub-
sequently validated for point-of-care (POC) use [1]. In this
research, a similar effort would be made to use AMPs as
biomarkers against pneumonia receptors.
Apart from this, several in silico tools exist to identify
novel AMPs that are fast, cheap, and less-labor intensive
thus speeding up the discovery process. Among them is the
Hidden Markov Models (HMMER) software which has sev-
eral modules to perform optimally using several command
lines. The high sensitivity of the HMMER profiles is due to
the combination of the scoring system in the form of E-
value. The E-value gives more information about the prob-
ability of that predicted AMPs to be true positive or false
negative AMPs [13, 14]. The appropriate use of the HMME
R algorithm enables a more sophisticated search of novel
peptides through scanning of the proteome.
This research work aimed to generate parameters for
AMPs that could be used as novel biomarkers for bacterial
pneumonia diagnosis with a view to speeding up accurate
diagnosis using in-silico technology such as HMMER. This
is because the discovery of more biomarkers is imperative,
using bioinformatics for example, for more accurate diag-
nosis and assurance of functional specificity to ameliorate
the aforementioned problems associated with pneumonia
biomarkers. With this, there is a potential promising per-
spective to reduce the problems of indiscriminate overuse,
toxicity due to the wrong prescription, bacterial resistance,
scarcity, and the high cost of existing antibiotics.
Results
Retrieval of anti-bacterial AMPs (BAP-AMPs)
In this section, experimentally validated AMPs were re-
trieved from various databases where literature mining re-
vealed that CAMP, APD, and BACTIBASE had 155, 9, and
4 experimentally validated bacterial anti-pneumonia anti-
microbial peptides (BAP-AMPs) respectively. BAP-AMPs
against the pathogens Klebsiella pneumonia totaled 140
peptides, Streptococcus pneumoniae totalled 16, and Acine-
tobacter baumannii totaled 12 peptides combined from the
various databases (see Table 1). These experimentally vali-
dated anti-pneumonia AMPs were derived from bacteria,
arthropods, Mammalia Amphibia, nematode, Pisces, Arach-
nida, aves, plants, reptilian, fungi, and viruses with the num-
bers for each division indicated in Table 1. The peptide
total in Table 1 represents unique peptides for each organ-
ism following the removal of duplicates.
Profile creation using HMMER
The first step in the profile creation pipeline was the
random grouping of the different classes into ¾ and ¼ of
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the experimentally validated AMPs. The ¾ is the train-
ing dataset, needed to train the algorithm to test
whether the functionally significant amino acid consen-
sus is conserved. After this, multiple alignments were
generated using HMMER ClustalW.
Independent testing of the created profiles
Each created profile was tested against a positive dataset
which represented about a quarter of the dataset, from
which the training dataset used for the construction of
the respective profiles was derived as well i.e. the profiles
created using training dataset must have the ability to
recognize and identify this subset of AMPs. Since experi-
mentally verified AMPs were used, the assumption is
that the profiles constructed should be able to identify
other sequences with the exact same activity and dis-
criminate those that have no anti-pneumonia activity
from same pathogen. The trained profiles were also
scanned against a negative control dataset, from UNI-
PROT database (http://www.uniprot.org) made up of
random fragments of 17,236 neuropeptides, which had
no recorded anti-pneumonia activity.
Evaluation of the independent testing results
The independent testing of the profiles were evaluated
using the true positive (TP), false positive (FP), true
negative (TN), and false-negative (FN). A cut-off E-value
of 0.05 was applied to the HMMER algorithm to
strengthen the ability of the profile to discriminate
between the true positive anti-pneumonia AMP and false-
negative anti-pneumonia AMPs. TP (True positive) repre-
sents correctly predicted positive sequences (anti-pneu-
monia AMPs), TN (True negative) denotes correctly
predicted negative sequences (non-anti-pneumonia
AMPs), FP (False positive) is the number of non-anti-
pneumonia AMPs wrongly predicted as anti-pneumonia
AMPs (AP-AMPs), FN (False negative) is the number of
anti-pneumonia AMPs wrongly predicted as non-anti-
pneumonia AMPs. It was possible to calculate the number
of TP AMPs from the total number of input sequences,
thus the FP number could be extrapolated with the results
shown in Table 2, reflecting the capacity of each profile to
distinguish true anti-pneumonia AMPs from false anti-
pneumonia AMPs.
Performance measurement of the target specific profiles
After evaluating the ability of the optimized profiles, the
performance was calculated with the aim of determining
the robustness of each profile, using specificity, sensitiv-
ity, accuracy and Matthew’s Correlation Coefficient
(MCC), introduced by biochemist Brian W. Matthews in
1975 [15]. The sensitivity, specificity, accuracy and MCC
were calculated as reported in Table 3.
From the result shown in Table 3, sensitivity values
were high in AB of anti-bacterial profiles tested. KP had
46%. All profiles were specific and accurate with signifi-
cant MCC values. The MCC is considered to give the
best performance measurement of models because it in-
corporates sensitivity, specificity, and accuracy [16]. The
specificity results for all profiles were 100%.
High sensitivity values of AB profiles showed correct
predictions. The moderate sensitivity of KP could be at-
tributed to the significant overlap in the conserved do-
main of the AMPs used for their profile construction
[17]. However, the relatively low sensitivity of SP could
be due to low available AMPs against Streptococcus
pneumoniae from the databases coupled with a serious
overlap in the conserved consensus [18]. The profiles
showed very significant accuracy results. Accuracy is a
commonly used predictive profile parameter to reduce
errors by establishing several misclassified AMPs from
both positive and negative datasets. MCC values for all
the profiles showed very significant results with the low-
est value recorded for SP (0.50). The MCC value ‘0.5 to
1’ corresponds to the perfect prediction, whereas ‘0’
points to a completely random prediction. Thus all pro-
files indicated correct prediction (AB > KP > SP).
Proteome sequence databases query and discovery of
putative anti-pneumonia AMPs
The discovery stage was to search for novel bacterial and
viral anti-pneumonia AMPs against Acinetobacter bau-
mannii, Streptococcus pneumoniae, Klebsiella pneumo-
niae toidentify peptides that had the same signatures/
motifs and properties as the input sequences used to
build the profiles AB, SP, KP. The matches of the re-
spective profiles to the proteome sequences were also
shown with E-values (Table 4). The E-value of 0.05 cut-
off was applied to search for putative AMPs.
Table 1 Profile creation by HMMER
Profiles Training Datasets Testing Datasets Total
AB 9 3 12
SP 12 4 16
KP 105 35 140
Legend: AB Anti-Acinetobacter baumannii, SP Anti-Streptococcus pneumoniae,
KP: Anti-Klebsiella pneumoniae
Table 2 Independent testing of profiles against test and
negative datasets
Profiles TP FN TN FP
AB 3 0 17,236 0
SP 1 3 17,236 0
KP 10 25 17,236 0
Legend: AB Anti-Acinetotobacter baumannii, SP Anti-Streptococcus pneumoniae,
KP, Anti-Klebsiella pneumoniae
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Scanning the profiles to identify novel anti-bacterial AMPs,
profile AB identified 7 AMP sequences that adhered to the E
value set which yielded 5 after removing the duplicate. Profile
SP identified 58 AMP sequences that adhered to E value set
which yielded 8 after removing duplicate while profile KP
identified 7 without duplicate. These anti-bacterial peptide
sequences were all single domains. These putative AMPs
were named by adding BOPAM to the trained profiles from
which they were derived (BOPAM-AB, BOPAM-SP, and
BOPAM-KP). BLAST analysis was used to eliminate
BOPAM-AB5 due to its 100% similarity to moricin whilst
BOPAM-KP1 was eliminated due to its 100% similarity to
drosomycin.
Physicochemical properties of the AMPs
The physicochemical properties of the putative AMPs
were determined using APD and BACTIBASE to ensure
that the identified sequences conform to other known
AMPs based on the characteristics measured (Table 5).
Physicochemical features such as molecular weight
amino acid composition, hydrophobicity, Boman index,
net charge, isoelectric potential, and half-life were used
to evaluate the anti-bacterial and anti-viral AMPs.
The amino acid composition of the AMPs contributes
to the molecular weight, since the AMPs are made up of
amino acids and can be a distinguishing feature to dis-
criminate between two classes of protein/peptides. The
antibacterial pneumonia AMPs have some amino acids
which are common to them for discrimination against
one another (Table 5). BOPAM-AB1–4 had common
amino acid leucine while BOPAM-AB5 had asparagine,
glycine, lysine, and valine. BOPAM-KP2 had asparagine;
BOPAM-KP3 had lysine and glycine; BOPAM-KP4–6
had lysine while BOPAM-KP7 had cysteine and serine.
BOPAM-SP1 had arginine; BOPAM-SP2–6 had glycine
while BOPAM-SP7 had glycine and valine. The anti-
pneumonia AMPs such as BOPAM-KP4, BOPAM-SP1,
and 2, had hydrophobicity less than 30% due to the pres-
ence of more polar amino acid residues (Table 5) [19].
All anti-bacterial pneumonia AMPs were positively
charged. Anti-bacterial pneumonia AMPs have pI be-
tween 6.22 and 12.91 (Table 5). This range of values
shows solubility properties for the AMPs despite the
variability of charges in acid and alkaline media [20].
The results of the Boman index showed negative values
for BOPAM-AB1–4 (Table 5). A negative Boman index
has been said to be positively correlated with a more
hydrophobic peptide, indicating a high protein binding
potential. The half-life results of the anti-bacterial pneu-
monia AMPs showed that BOPAM-AB1–4 had 1.1 h;
Table 3 Summary of Performance measurement of the profiles
Models Sensitivity (%) Specificity (%) Accuracy (%) MCC
AB 100 100 100 1
SP 25 100 99.6 0.50
KP 46 100 99.9 0.63
Legend: AB Anti-Acinetobacter baumannii, SP Anti-Streptococcus pneumoniae,
KP Anti-Klebsiella pneumoniae
Table 4 Final list of the Anti-bacterial pneumonia AMPs with their sources
S/N TARGET ORGANISMS E-VALUE SEQUENCE
1 BOPAM-AB1 Amphibian predicted 0.0076 FLPI----LKSGLSGLL
2 BOPAM-AB 2 Amphibian predicted 0.0091 FFP----LLKSGLSGLL
3 BOPAM-AB3 Amphibian predicted 0.014 FFP----LLKFGLFGLL
4 BOPAM-AB4 Amphibian predicted 0.02 FFP----LLKFGLSGLL
5 BOPAM-KP 2 Atta cephalotes 0.008 MWK----GGLNNGVQCKIDNC
6 BOPAM-KP 3 Atta cephalotes 0.009 MWK----LGNNFTVQCKIDNC
7 BOPAM-KP 4 Atta cephalotes 0.010 IHH----GGYIPYLKWHLRKK
8 BOPAM-KP 5 Drosophila erecta 0.011 ICK----ISGHCSASLKCWFKKR
9 BOPAM-KP 6 Drosophila mojavensis 0.013 LAK----AGAEKKKCKELAKK
10 BOPAM-KP 7 Drosophila erecta 0.015 LCR----VSGHCSASLKCWRAMK
11 BOPAM-SP1 Homo sapiens 6.9e-16 QGRDD----SIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNG
12 BOPAM-SP2 Felis catus 5.1e-11 KGRND----SMMERRGLTTPCKDTNTFIHGNKGSIKAICGNKNG
13 BOPAM-SP3 Bos Taurus 5.2e-10 FRH----GEYEVHHQKLVFFAEDVSGSNKGFCAIIGLMVGGVVI
14 BOPAM-SP3 Homo sapiens 5.3e-10 FRH----GEYEVHHQKLVFFAEDVSGSNKGFCAIIGLMVGGVVI
15 BOPAM-SP4 Latimeria chalumnae 1.5e-09 FRH----GEYEVHHQKLVFFAEDVSGSNKGFCAIIGLMVGGIVI
16 BOPAM-SP5 Felis catus 6e-09 FRH----GEYEVHHQKLVFFAEDVSGSNKGFCAIIGLMVGGVVI
17 BOPAM-SP 7 Xenopus amphibians query 2.9e-07 YRH----GEYEVHHQKLVFFAEEVSGSNKGFCAIIGLMVGGVVI
LEGEND: S/N Serial number, BOPAM-AB1–4 Putative Anti-Acinetobacter baumannii AMP, BOPAM-SP1–8 Putative Anti-Streptococcus pneumoniae AMP, BOPAM-KP2–7
Putative Anti-Klebsiella pneumoniae AMP
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BOPAM-KP2–4 had 30 h, BOPAM-KP5 had 20 h while
BOPAM-KP6 and 7 had 5.5 h. BOPAM-SP1 had a half-
life of 0.8, BOPAM-SP2, and 7 had a half-life of 1.3,
BOPAM-SP3–6 had a half-life of 1.1 while BOPAM-SP7
had a half-life of 2.8.
Retrieval of protein receptors of pneumonia pathogens
This section was carried out to determine the immuno-
genic proteins of bacterial pneumonia of diagnostic rele-
vance to serve as targets for the novel antimicrobial
peptides for the diagnosis of the different pathogens. Sev-
eral pneumonia proteins such as cell surface receptors and
nucleoproteins were identified for the pneumonia patho-
gens Acinetobacter baumanni, Streptocococcus pneumoniae,
Klebsiella pneumoniae. These protein receptors of pneu-
monia pathogens were retrieved from the protein databank
(PDB) in National Centre for Bioinformatics Institute
(NCBI) database and are projected to be potentially relevant
in the diagnosis of bacterial pneumonia pathogens.
Acinetobacter baumannii is an emerging nosocomial
pathogen that is resistant to many types of antibiotics, and
hence, a fast, sensitive, specific, and economical test for its
rapid diagnosis is needed. Analysis of the pneumonia
pathogen proteins from APD and BACTIBASE showed
that Acinetobacter baumannii has an iron-regulated outer
membrane receptor protein with molecular weight 85,
519.34 Da, isoelectric point 7.55, hydrophobicity 31.22%,
charge + 1, instability index 25.61, and Half-life of 30 h in
mammals. Streptococcus pneumoniae is presumed to be
the primary bacterial cause of community-acquired lower
respiratory infections and meningitis among children and
the elderly in many countries. The laboratory diagnosis of
invasive pneumococcal disease continues to rely on
culture-based methods from appropriate clinical samples
such as blood, pleural fluid, or purulent sputum that have
been used for many decades. Pneumolysin was identified
for Streptococcus pneumoniae, which has a molecular
weight of 52,896.42 Da, an isoelectric point of 5.18, hydro-
phobicity of 33.97%, charge − 14, instability index of 20.69,
and Half-life of 30 h in mammals (Table 6). Evidence indi-
cates that Klebsiella pneumoniae infections are character-
ized by a lack of early inflammatory response, thus
making detection difficult. However, it is unknown
whether Klebsiella pneumoniae employs additional factors
to modulate host inflammatory responses to escape detec-
tion. Results indicated that Klebsiella pneumoniae has an
iron-regulated outer membrane protein with molecular
weight 80,401.89 Da, isoelectric point 4.89, hydrophobicity
32.37%, charge − 24, instability index of 35.81, and Half-
life of 30 h in mammals (Table 6).
Final list of the pneumonia receptors
Structure prediction of the putative anti-pneumonia AMPs
and pneumonia protein receptors
Representative output images from the I-TASSER server
after predicting the 3-D structures of the anti-pneumonia
AMPs (ligands) and the protein receptors are indicated in
Fig. 1. The results indicate that all AMPs predicted
Table 5 Physicochemical parameter of the anti-bacterial pneumonia putative AMPs
S/N Profile Mass number (Da) % Hydrophobic Common amino acid Net charge PI Boman Index (kcal/mol) Half-life (Hours)
1 BOPAM-AB1 1755.35 52 L + 2 10.81 − 1.55 1.1
2 BOPAM-AB2 1789.36 52 L + 2 10.81 −1.43 1.1
3 BOPAM-AB3 1909.56 64 L + 2 10.81 −2.18 1.1
4 BOPAM-AB4 1849.46 58 L + 2 10.81 −1.81 1.1
5 BOPAM-KP2 2370.21 42 NKGV + 2 8.70 0.9 30
6 BOPAM-KP3 2478.35 47 NKV + 3 8.82 1.18 30
7 BOPAM-KP4 2532.14 28 K + 7 10.58 1.5 20
8 BOPAM-KP5 2667.29 39 K + 5 9.66 2.3 20
9 BOPAM-KP6 2300.00 38 K + 8 10.98 2.28 5.5
10 BOPAM-KP7 2589.16 43 CS + 4 8.53 2.0 5.5
11 BOPAM-SP1 5083.36 27 R + 6 10.06 3.62 0.8
12 BOPAM-SP2 4903.88 25 G + 6 10.00 3.06 1.3
13 BOPAM-SP3 4765.02 45 G + 1 6.22 0.47 1.1
14 BOPAM-SP4 4779.05 45 G + 1 6.22 0.45 1.1
15 BOPAM-SP5 4779.05 45 G + 1 6.22 0.43 1.1
16 BOPAM-SP6 4765.02 45 G + 1 6.22 0.47 1.1
17 BOPAM-SP7 4793.07 47 GV + 1 6.22 0.36 2.8
LEGEND: S/N Serial number, BOPAM-AB1–5 Putative Anti-Acinetobacter baumannii AMP, BOPAM-SP1–8 Putative Anti-Streptococcus pneumoniae AMP, BOPAM-KP1–2
Putative Anti-Klebsiella pneumoniae AMP
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exhibited various secondary structures including α-helices,
parallel β-sheet, anti-parallel β-sheet, extended, and loop
conformational structures (Fig. 1). The results observed
are in line with the various structural conformations ex-
hibited by known AMPs. Examples of known AMPs and
their structures include tachyplesin from horseshoe crabs
and bovine lactoferricin which have beta-sheet conforma-
tions [21]; magainin analog and melittin having alpha-
helical conformations [22].
For structure prediction evaluation using I-TASSER
(Table 7) several parameters such as C-score, TM-score,
and RMSD were used for the prediction of the AMPs
and pneumonia protein receptor 3-D structures.
C-Score C-score is a confidence score for estimating the
quality of predicted models by I-TASSER. Its calculation
is based on the significance of threading template align-
ments and the convergence parameters of the structure
assembly simulations, which is typically in the range of − 5
to 2, where a C-score within this range of values, signifies
a model with high confidence (Zhang, [23]). The results
indicate that the C-score of all the predicted 3-D struc-
tures for the anti-bacterial pneumonia AMPs and the
pneumonia receptor proteins were between the values of
− 5 to 2 (see Tables 7, 8, 9, and 10) especially the C-score
of the pneumonia receptor proteins. The calculated C-
scores of BOPAM-KP2, 3 (Table 9), 4, BOPAM-SP3, 4,
and 6 (Table 10) were lower than that of the other AMPs;
and could indicate that these molecules did not have an
available template for their prediction but were still not
randomly predicted (Roy et al., [24]). The lack of tem-
plates for the prediction of these molecules can indicate
their novelty. A TM-score > 0.5 indicates a model of cor-
rect topology and a TM-score < 0.17 means a random
similarity. These cut-offs do not depend on the protein
length. From the results (Tables 7, 8, 9, and 10), the TM-
score of the predicted structures of the AMPs were higher
than the cut-off value of 0.5, except for BOPAM-KP2 with
a TM-score of 0.49 ± 0.15. BOPAM-KP2 also had a lower
than expected C-score adding to the notion that there are
no templates for this particular molecule at the time of
the study. Although there is not a defined RMSD value for
3-D structure prediction, an RMSD value of 2–4 Å is con-
sidered good and an RMSD ≤1 Å is considered ideal.
Docking interaction analysis of the putative anti-
pneumonia AMPs with bacterial pneumonia receptors
The output images from the PATCHDOCK server after
predicting the docking interaction between the anti-
pneumonia AMPs (ligands) and the protein receptors
were analysed (Fig. 2). The spatial docking interaction
analysis showed that all the AMPs bound tightly to their
respective proteins, indicating significant diagnostics since
the geometry binding scores were higher than 8741 [25].
Discussion
Only experimentally validated AMPs were retrieved
from the various databases since they have proven activ-
ity against the target pathogens with minimum inhibi-
tory concentration (MIC) as indicator using the agar
Table 6 Physicochemical Properties of the Retrieved Pneumonia Receptor Proteins
S/N Anti-Pneumonia proteins Molecular weight (Da) Hydrophobicity (%) Net charge Instability index Half-life
(hours)
1 AB Iron regulated OMP 85,519.34 31.22 + 1 25.61 30
7 SP Pneumolysin 52,896.42 33.97 −14 20.69 30
8 KP Iron regulated OMP 80,401.89 32.37 −24 35.81 30
AB Acinetobacter baumanni, SP Streptocococcus pneumoniae KP Klebsiella pneumoniae
Fig. 1 3D structures of the AMPs and pneumonia protein as determined by I-TASSER. 3D structure of (a) Acinetobacter baumannii outer
membrane protein (b1) alpha helical AMP, (b2) beta sheet AMP, (b3) extended sheet AMP
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dilution or broth microdilution methods [26]. Experi-
mentally validated AMPs were used since their activities
have been proven. These activities would be retained in
the newly retrieved AMPs since HMMER creates a pro-
file by retaining the functionally significant amino acid
residues. The list of anti-pneumonia AMPs was retained
within their respective pathogenic target groups as re-
trieved from the various databases to allow for specific
species/pathogen profile creation. This step prevents the
profile being sensitive to small misalignments and to re-
port reliable E-values in order to capture the diversity of
the sequences since the AMPs were derived from differ-
ent organisms [27]. Clusters by HMMER also allow a
minimum amount of similarity between all peptides. A
total of three AMP profiles were created for each of the
following classes (anti-Streptococcus pneumoniae (SP),
anti-Acinetobacter baumannii (AB) and anti-Klebsiella
pneumoniae (KP)).
The profiles were tested using positive and negative
datasets where the strength of the created profiles lies in
its high discriminatory power. It is assumed that the
AMPs used for the construction of the respective profiles
have known anti-pneumonia activity as seen by the experi-
mental evidence provided by the literature [26]. This inde-
pendent testing was done with the negative dataset
(neuro-peptides) to confirm whether the trained profiles
would discriminate against non-anti-pneumonia peptides.
This method of taking random sequences as a negative
dataset is a routinely used procedure [28] and this is based
on the assumption that probability of finding random
sequences with a highly discriminative profile is very low.
In Table 2, AB had all its testing datasets as true posi-
tive but KP had 10 of its 35 testing datasets as true posi-
tive while SP had one of its four testing as true positive.
All the anti-bacterial profiles discriminated against the
neuropeptides as it was expected. The lower hit observed
for the KP and SP profiles is as a result of an overlap of
homologous relationship in the AMPs used in their pro-
files [29]. HMMER used a default E value of 0.05 for
every hit considered to be true positive. All anti-bacterial
profiles yielded true positive with E values lower than
0.05 indicating that there was only a 5% chance that the
hit was false or random, i.e. true positive with an E value
less than 0.05 is considered ideal, indicating an ex-
tremely high confidence.
Specificity estimates true negative rate by calculating
the proportion of the negative datasets that were cor-
rectly predicted [30]. A poor specificity results when
AMP profiles have closely related functions with other
profiles. The specificity results for the profiles indicate
that they did not have closely related functions with any
other profiles. Sensitivity is the measure of the true
positive rate which represents the ratio of the correctly
predicted positive datasets to the total number of the
positive datasets [31]. Low or moderate sensitivity is only
possible where a false-positive might score higher than a
true-positive. In this case, however, the model discrimi-
nated against all false-positive but some true-positive in
KP and SP behaved as true-negative, strengthening further
the case of overlapping consensus in the conserved do-
mains. Accuracy considers interactions between features
of AMPs by discriminating them against non-AMPs, even
from similar accuracy values in other machine learning
methods [32]. The accuracy results were very high for all
the profiles indicating elimination of errors by nullifying
misclassified AMPs from both positive and negative data-
sets. MCC is considered as the most robust parameter for
evaluating the prediction of profiles. This is because it of-
fers an advantage by increasing the understanding of the
relationship between sensitivity, specificity and accuracy;
reduces uncertainty through identification of profiles that
are defective significantly; and searches for errors in the
Table 7 Quality assessment scores of the predicted 3-D structures of the bacterial pneumonia receptors
S/N Anti-Pneumonia proteins C-score Exp. TM Score Exp. RSMD
1 AB Iron regulated OMP −0.18 0.69 ± 0.12 2.8 ± 1.6 Å
2 SP Pneumolysin 1.77 0.96 ± 0.05 3.5 ± 2.4 Å
3 KP Iron regulated OMP −0.47 0.70 ± 0.12 2.5 ± 1.5 Å
S/N Serial number, AB Acinetobacter baumanni, SP Streptocococcus pneumoniae, KP Klebsiella pneumoniae
Table 8 Quality assessment scores of the predicted 3-D
structures of the putative anti-Acinetobacter baumannii AMPs
S/N Putative AMP C-Score Exp. TM Score Exp. RSMD
1 BOPAM-AB1 −0.51 0.65 ± 0.13 1.6 ± 1.4 Å
2 BOPAM-AB2 −0.49 0.65 ± 0.13 1.6 ± 1.4 Å
3 BOPAM-AB3 −0.27 0.68 ± 0.12 1.2 ± 1.2 Å
4 BOPAM-AB4 −0.32 0.67 ± 0.13 1.3 ± 1.3 Å
Table 9 Quality assessment scores of the predicted 3-D
structures of the putative anti-Klebsiella pneumonia AMPs
S/N Putative AMP C-Score Exp. TM Score Exp. RSMD
1 BOPAM-KP2 −1.84 0.49 ± 0.15 4.5 ± 3.0 Å
2 BOPAM-KP3 −1.55 0.52 ± 0.15 3.9 ± 2.7 Å
3 BOPAM-KP4 −1.52 0.53 ± 0.15 3.9 ± 2.6 Å
4 BOPAM-KP5 −0.18 0.69 ± 0.12 1.6 ± 1.4 Å
5 BOPAM-KP6 −0.06 0.71 ± 0.12 1.2 ± 1.2 Å
6 BOPAM-KP7 −0.39 0.66 ± 0.13 1.9 ± 1.6 Å
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model [33]. This result agrees with the work of Bhadra,
Yan [34] where performance was compared in terms of
accuracy, precision, Mathew and Correlation Coefficient
(MCC) using benchmark datasets as inputs.
A final list of AMPs was identified and the AMPs were
ranked according to their E-values with those having the
smallest E-values considered the most likely putative
anti-pneumonia AMPs. There was a very low probability
that these peptides were wrongly predicted to be anti-
pneumonia AMPs. The consequence of the presence of
charged, polar, and non-polar amino acids to the anti-
bacterial putative AMPs is the conferment of charge, re-
duced or increased hydrophobicity, and reduced or in-
creased binding potential on them. The resultant effect
of reduced hydrophobicity on the non-polar face of the
amphipathic helix of BOPAM-KP4, BOPAM-SP1, and 2
is poor peptide helicity, reduced self-associating ability
in aqueous environments, and poor antimicrobial activ-
ity. Peptides with higher hydrophobicity would penetrate
deeper into the hydrophobic core of the bacterial mem-
brane, causing stronger hemolysis by forming pores or
channels [35]. Thus, the antibacterial AMPs with increased
hydrophobicity could potentially penetrate the membrane
core. Reduced hydrophobicity is a consequence of polar
amino acids. Recently, AMPs from sugar-functionalized
phosphonium polymers have been reported to require the
hydrophilic domains in their molecular structure to exert
anti-bacterial activities against Gram-negative Escherichia
coli and Gram-positive Staphylococcus aureus [36]. Cat-
ionic AMPs are said to be positively correlated with in-
creased anti-microbial activities (Table 5). Therefore all the
anti-bacterial AMPs which were positively charged indi-
cated conformity with ideal AMPs with improved anti-
microbial activities [37]. Isoelectric potential (pI) of pep-
tides is a function of individual amino acids in both back-
bone groups. At a pH below the pI, AMPs carry a net
positive charge and vice versa. A more hydrophilic peptide
tends to have a more positive index. However, the ten-
dency of some peptides to have a positive Boman index
has been reported with the ability to detect HIV in a lateral
flow device [12]. The use of physicochemical parameters as
indices to evaluate AMPs is in agreement with the work of
Hollmann, Martinez [38] where a re-evaluation of the
physicochemical properties of antimicrobial peptides was
investigated, resulting in a characteristic thermal transition
profile in model vesicles which was used to categorize
novel molecules with unknown biological activity.
Acinetobacter baumannii iron-regulated outer membrane
protein has a strong potential as a receptor for the diagnosis
of pneumonia caused by this organism. The protein is well-
conserved throughout evolution and stable in vitro as indi-
cated by its instability index of 25.61 (see Table 6). A pro-
tein whose instability index is smaller than 40 is predicted
as stable in vitro. Studies have shown that the outer mem-
brane protein (Omp) of Acinetobacter baumannii can be
used as candidate bio-molecules in animal models for
detection tests [39]. This protein possesses attributes such
as outer membrane localization, high adhesion probability
(0.53), possession of a single transmembrane helix and
absence of homology to the human protein, presence of B-
cell and T-cell epitopes binding with the high affinity of
40% survival rate for passive immunization and 20% for ac-
tive in its outer membrane protein and have been explored
for in silico technology to select promising diagnostic can-
didate [40]. The most significant recent developments in
the diagnosis of pneumonia have occurred with antigen de-
tection assays using pneumolysin [41]. The use of pneumo-
lysin is very essential for S. pneumoniae diagnosis because
it is produced in high concentration and stable in different
body fluid samples across virtually all clinical isolates. Be-
sides, based on the protein’s physicochemical properties
using the charge, instability index, and half-life, pneumoly-
sin is an attractive candidate receptor for the diagnosis of
Streptococcus pneumoniae. The iron-regulated outer mem-
brane protein is being used for the detection of K.
Table 10 Quality assessment scores of the predicted 3-D
structures of the putative anti-Streptococcus pneumonia AMPs
S/N Putative AMP C-Score Exp. TM Score Exp. RSMD
1 BOPAM-SP1 −0.05 0.71 ± 0.12 2.5 ± 1.9 Å
2 BOPAM-SP2 −0.00 0.71 ± 0.11 2.4 ± 1.8 Å
3 BOPAM-SP3 −1.74 0.50 ± 0.15 5.8 ± 3.6 Å
4 BOPAM-SP4 −1.70 0.51 ± 0.15 5.7 ± 3.6 Å
5 BOPAM-SP5 −1.71 0.51 ± 0.15 5.7 ± 3.6 Å
6 BOPAM-SP6 −1.75 0.50 ± 0.15 5.8 ± 3.6 Å
7 BOPAM-SP7 −0.08 0.70 ± 0.12 2.6 ± 1.9 Å
BOPAM-AB Anti-Acinetobacter baumanni AMPs, BOPAM-SP Anti-Streptocococcus
pneumoniae AMPs, BOPAM-KP Anti-Klebsiella pneumoniae AMPs
Fig. 2 Representative of the docking interaction of a protein
receptor and putative anti-pneumonia AMPs produced by PATC
HDOCK and visualized using PyMol. BOPAM-AB3, 2, and 4 had
higher binding affinity than all anti-Acinetobacter baumannii AMPs,
BOPAM-SP2, and 6 had higher binding affinity than all anti-
Streptococcus pneumoniae AMPs whilst BOPAM-KP2 and 6 had
higher binding affinity than all anti-Klebsiella pneumoniae AMPs
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pneumoniae using antibody detection because it is well-
conserved throughout evolution and stable across clinical
samples. The use of receptor protein candidates such as
Klebsiella pneumoniae iron-regulated outer membrane pro-
tein [42], Acinetobacter baumannii iron-regulated outer
membrane protein [43], Streptococcus pneumoniae pneumo-
lysin [44], in the diagnosis of pneumonia is justified because
they are produced in relatively high amount inside body
fluid across all strains and subtypes of these pathogens; do
not change with time; highly accessible either as cell surface
receptor and relatively stable in a mild in vitro handling.
These receptors were therefore retained for further analysis.
Following the prediction of the putative anti-
pneumonia peptides, it still had to be concluded whether
these sequences can be considered bona vide AMPs. To
classify these sequences as bona vide AMPs it had to
conform to known AMPs in terms of characteristics as
well as structure. As seen in the physicochemical
characterization section of the sequences which was car-
ried out on the predicted peptides indicating that the
peptides conform to known AMPs. In this section, the
structures of the peptides were predicted and the results
indicates that these peptides conform to known AMPs
using structure as the measurement. Taken together, it
can be concluded that based on their characteristics and
structure, these peptides can be considered bona vide
AMPs. However, the AMPs are still considered putative
anti-pneumonia peptides due to lack of experimental
evidence for these molecules currently.
The C score value of the putative anti-pneumonia pep-
tides 3-D structures indicate they have already been
solved indicating existing templates within protein data-
bases for use by I TASSER for their structural prediction
except for BOPAM-KP2, 3, 4, BOPAM-SP3, 4. TM-
score, on the other hand, is a recently proposed scale for
measuring the structural similarity between two struc-
tures [45]. AMPs with TM-scores higher than 0.5, signi-
fies structural similarity with the templates that were
used to predict their structures [23, 24]. All anti-bacteria
AMPs having RMSD within the accepted range (see Ta-
bles 7, 8, 9, and 10) had less distance and the atomic de-
viation between the superimposed peptides and the
templates, which were used for their 3-D structure pre-
diction [46, 47]. The purpose of proposing TM-score is
to solve the problem with RMSD, which is sensitive to
local error since RMSD is an average distance of all resi-
due pairs in two structures. For instance, a misorienta-
tion of the structure will give rise to a big RMSD value
although the global topology of the structure is correct.
TM-score is not sensitive to misorientation in the dis-
tance of the residues which makes the score insensitive
to the local modeling error and thus a more reliable
measure. Both TM and RMSD scores are known stan-
dards for measuring structural similarity between two
structures for accuracy of structure modeling when the
native structure is known [24]. The C-score is a metric
developed for I-TASSER to estimate the confidence of
the modeling, however, when the native structure is un-
known, it becomes imperative to predict the quality of
the modeling, that is, the distance between the predicted
model and the native structures. This is the reason for
calculating the TM and RMSD scores of the predicted
models relative to the native structures which are based
on the C-scores.
Using this criteria of binding geometric score from
Table 11 above, BOPAM-AB3, 2 and 4 would be better
diagnostic molecules for the detection of Acinetobacter
baumannii since these peptides showed the highest
binding geometry scores compared to any other putative
anti-Acinetobacter baumannii AMP. In addition,
BOPAM-SP2 and 6 (Table 11) would be the better diag-
nostic molecules against Streptococcus pneumoniae
based on the peptides observed binding geometry scores
to this organism’s identified receptor. Furthermore,
BOPAM-KP2 and 6 (Table 11) showed the highest bind-
ing geometry scores to the Klebsiella pneumoniae identi-
fied receptor than any other BOPAM-KPs.
Conclusions
AMPs have shown great promise in circumventing the
drawbacks associated with the current diagnostic sys-
tems. Eighteen putative AMPs were identified from the
use of HMMER for these bacterial pathogens for use in
the differential diagnosis. This research offers new in-
sights into the in silico modular architecture, the evolu-
tion of host defense molecules containing core motifs,
and diagnostic helices associated with antimicrobial ac-
tivity of putative AMPs functions against bacterial pneu-
monia pathogen. The main goal of this in silico
diagnostic system is to ease the search for early detec-
tion. This would assist medical practitioners towards the
correct treatment plan and subsequently, enable patients
to develop accommodating lifestyles. This research work
could be pursued for molecular validation through the
binding of these AMPs with the bacterial proteins re-
spectively, using an “on/off” binding experiment in an
LFD setting to develop a prototype with these specific
AMPs conjugated to gold nanoparticles (AuNPs) to ac-
curately and sensitively detect the viral and bacterial
pathogens within patient samples. Future work will in-
clude the site-directed mutagenesis of the putative
AMPs to optimize them into more potent candidate
diagnostic molecules. This would be followed by an
in vitro study of the anti-pneumonia activity of the mu-
tated peptides. Also, the EC50 of all the AMPs and their
therapeutic or selective index will be assessed for the op-
timized AMPs. The anti-pneumonia activity of these
AMPs will be carried out on different pseudotypes of the
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pneumonia pathogens to determine their broad-
spectrum activity. Finally, the binding complex formed
between the pathogen receptors and putative AMPs will
be solved using structural biology to validate the obser-
vations made by the in silico binding study.
Methods
Data retrieval (literature mining)
The experimentally validated anti-pneumonia AMPs for
the bacterial causative agents (Streptococcus pneumoniae,
Acinetobacter baumannii, and Klebsiella pneumoniae)
were retrieved manually from antimicrobial peptide data-
bases such as Antimicrobial Peptides Database (APD) [48,
49], Collection of Antimicrobial Peptides (CAMP) [50].
Thereafter, curation was carried out through literature
mining to confirm that all the retrieved AMPs were either
experimentally validated or predicted. Duplicate experi-
mentally validated AMPs were then discarded from the
list using the Cluster Database at High Identity with Tol-
erance (CD-HIT) [51].
Training and testing datasets (data mining)
The final list of the experimentally validated AMPs was
categorized according to their specific pathogenic agents
with AB denoting anti-Acinetobacter baumannii; SP -
anti-Streptococcus pneumoniae; KP - anti-Klebsiella
pneumoniae. Each category of the aforementioned data-
sets was randomly divided into two portions: three-
quarters of each data set was utilized as the training set
(to build each profile), whilst one-quarter was used as
the testing dataset (for optimization/calibration of the
created profiles).
Construction of AMPs profiles (text mining)
The Hidden Markov Models (HMMER) algorithm ver-
sion 2.3.2 [52] was used to construct specific pathogen-
targeted models/profiles using the respective training
datasets. All the HMMER profiles were built on the
Ubuntu 12.04 LTS operating system. The task was ac-
complished on a terminal and the command lines used
to build each profile was written following the corre-
sponding algorithm and the steps involved in their con-
struction were as below:
For the first step, the training datasets of each target
class were aligned using the ClustalW alignment tool [53].
The alignment was carried out using the command line:
The command line simply states <<do an alignment of
the sequences which are in the upper case found in the
input file “target class.fasta” with the FastA, using Clus-
talW as multiple alignment tools and GCG Postscript
output for graphical printing>>. The output of the com-
mand results in the construction of aligned sequences,
called “target class.msf”. The aligned sequences were
used as input in the next step.
The next step enhances the construction of the pro-
files of the target class sequences by showing the com-
mon motifs/signatures within the profiles. To achieve
Table 11 Quality assessment scores of the docking analysis for the anti-pneumonia putative AMPs and the pneumonia receptors
S/N Receptors Ligands Binding Scores
1 Iron regulated outer membrane protein BOPAM-KP2 13,036
2 Iron regulated outer membrane protein BOPAM-KP3 12,384
3 Iron regulated outer membrane protein BOPAM-KP4 12,960
4 Iron regulated outer membrane protein BOPAM-KP5 10,810
5 Iron regulated outer membrane protein BOPAM-KP6 13,208
6 Iron regulated outer membrane protein BOPAM-KP7 12,092
7 Pneumolysin BOPAM-SP1 12,306
8 Pneumolysin BOPAM-SP2 13,606
9 Pneumolysin BOPAM-SP3 12,116
10 Pneumolysin BOPAM-SP4 12,384
11 Pneumolysin BOPAM-SP5 12,514
12 Pneumolysin BOPAM-SP6 13,306
13 Pneumolysin BOPAM-SP7 11,830
14 Iron Regulated OMP BOPAM-AB1 10,566
15 Iron Regulated OMP BOPAM-AB2 11,806
16 Iron Regulated OMP BOPAM-AB3 12,480
17 Iron Regulated OMP BOPAM-AB4 11,802
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this, the “Build profiles” was run using the following
command:
To enhance the sensitivity of the profiles, the file gener-
ated (target class. hmm) from the profile building step
was calibrated by using the command line:
The resulting profiles “target class.hmm” was used in
evaluating the performance of the profiles by testing the
created profiles on an independent AMP dataset.
Independent profile testing
The independent testing of each created profile was per-
formed in a step called “Query profiles”. The testing and
negative datasets were queried against the created profiles
using the command line, with an E-value threshold of 0.05:
Performance measurement of each profile
Statistical performance measures were then calculated
using sensitivity, specificity, accuracy and Mathew Cor-
relation Coefficient as parameters. The measures used
were employed accordingly.
Scanning the profiles for motifs discovery across the
proteome sequences
Proteome sequences were scanned by the respective pro-
files/predictive profiles with the list of all proteome se-
quences (in the fasta format) retrieved, from the
Ensembl database (http:// www.ensembl.org/index.html)
and the UniProt database (http://www.uniprot.org/) for
the identification of putative anti-pneumonia AMPs. A
cut-off E-value was set to be 0.05 for the search of puta-
tive anti-pneumonia AMPs. This was accomplished
using “hmmsearch” module of the HMMER algorithm
with the command line employed stated below:
Where specific target class.hmm in one of the six profiles,
target class query.txt representing the species scanned against
the profile, and resultfile.txt is the result file saved after query-
ing that species against a particular pathogen profile.
Identification of receptors
Bacterial receptors, such as cell surface receptors, were
identified for the bacterial causative agents (Streptococcus
pneumoniae, Acinetobacter baumannii, and Klebsiella
pneumoniae) implicated in pneumonia to serve as targets
for the identified AMPs.
Protein retrieval
Bacterial pneumonia proteins were collected from vari-
ous protein data banks (PDB) such as National Centre
for Biotechnology Information (NCBI), UniProt, Google
Scholar, and Ensembl through literature mining. There-
after, curation was performed to verify that all the re-
trieved pathogen pneumonia proteins were complete or
partial. Partial proteins were discarded and complete
protein was kept for further analysis. BLAST analysis
was performed using the UniProt interface for further
assurance of specificity with E threshold of 0.01 such
that the bacterial pneumonia proteins of interest were
not present in other bacteria and viruses.
Physicochemical properties of the putative anti-
pneumonia AMPs and the pneumonia proteins
Physicochemical properties of the putative anti-
pneumonia AMPs and their respective protein receptors
were calculated using the prediction interface of Bacti-
base (http://bactibase.pfba-lab-tun.org/physicochem) [54,
55] and APD ((http://aps.unmc.edu/AP/design/design_
improve.php)) [48, 49] using the amino acid sequences
of the putative peptides and receptor proteins as input.
De novo structure predictions of the putative anti-
pneumonia AMPs and pneumonia proteins (ligands)
Prediction of the top ranking putative anti-pneumonia
AMPs structures, based on their predictive E-values, as well
as the structure of pneumonia bacterial proteins was per-
formed using I-TASSER (Iterative Threading ASSembly Re-
finement) server, which is an example of a de novo method
of peptide or protein structure prediction (Eswar and Sali,
[56]). In brief, the 3-D structures of the anti-Pneumonia
AMPs and specific bacterial pneumonia protein was pre-
dicted by uploading each sequence onto the I-TASSER
website. The users enters their email addresses into which
the results link will be sent. After, naming the uploaded se-
quence, the menu “Run I-TASSER” was selected (Roy et al.,
[24]). The 3-D structures of the AMPs and their respective
protein receptors were visualized using the PyMOL version
1.3. This was achieved by downloading the latest version of
the PyMol on Ubuntu Linux, extracting and installing it
using the terminal command line.
Docking analysis of the putative anti-pneumonial AMPs
and Pneumonial proteins
The docking of the anti-bacterial AMPs to their respect-
ive pneumonia proteins was carried out using PatchDock
Beta 1.3 version, a free online web-server that enables
the docking of the protein-small ligand molecule, avail-
able at http://bioinfo3d.cs.tau.ac.il/PatchDock/ (Schneid-
man-Duhovny et al., [57]). In brief, the 3-D structures of
the anti-bacterial pneumonia putative AMPs and the
bacterial pneumonia protein receptors PDB files from I-
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TASSER onto the PatchDock server website, after which
the user enters an email address. The cluster RMSD was
set to 4.0 Å and the “protein-small ligand” was selected
for complex type. The task was submitted by selecting
“the Submit Form”. The docking results were deposited
via an email notification containing the web link to the
docking results. Interaction analysis of the complex for-
mation between the anti-bacterial pneumonia putative
AMPs and their respective pneumonia protein receptors
was done using PyMol version 1.3.
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